Efficacy of myoinositol in treatment of gestational diabetes mellitus in Asian Indian women: A pilot randomized clinical trial

Gestational diabetes mellitus (GDM) is glucose intolerance diagnosed during pregnancy that is not clearly overt diabetes [1]. The International Diabetes Federation estimated globally 15.8% of women with live births in 2019 had hyperglycemia in pregnancy; of which 83.6% were due to GDM [2]. GDM is associated with increased maternal and perinatal morbidity and also the long-term consequences, includingtype-2 diabetes and cardiovascular complications in mothers, and obesity and adult onset diabetes in children born to these mothers [3].

Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - February 18, 2021 Category: OBGYN Authors: Vidushi Kulshrestha, Shrey Balani, Garima Kachhawa, P. Vanamail, Rajesh Kumari, J.B. Sharma, Neerja Bhatla Tags: Full length article Source Type: research